Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/16/2003WO2003084979A2 Novel peptides and the application thereof in therapy
10/16/2003WO2003084574A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003WO2003084566A2 Proteins involved in the regulation of energy homeostasis
10/16/2003WO2003084565A2 Ve-ptp as regulator of ve-cadherin mediated processes or disorders
10/16/2003WO2003084563A1 Glp-1 agonist and cardiovascular complications
10/16/2003WO2003084562A1 Chemokines mutants having improved oral bioavailability
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084483A2 Methods for modulating angiogenesis via vegf
10/16/2003WO2003084477A2 Mammalian cdr mimetibodies, compositions, methods and uses
10/16/2003WO2003084472A2 Recombinant p. falciparum merozoite protein-142 vaccine
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003084445A1 Device for mixing and/or injecting cements
10/16/2003WO2003084314A1 Plant with improved organogenesis and method of constructing the same
10/16/2003WO2003084312A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003WO2003072791A3 Transgenic fodder plants with an increased leaf starch content
10/16/2003WO2003070963A3 Improved protein expression in bacillus subtilis
10/16/2003WO2003068954A3 Microorganism for genetic therapeutic treatment of proliferative diseases
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003066902A3 Pyrrolidinyl peptide nucleic acids
10/16/2003WO2003065977A9 Modified antigen-presenting cells
10/16/2003WO2003064595A3 Recombinant herpesvirus of turkeys and use thereof
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059935A3 Methods for purifying protein
10/16/2003WO2003057729A3 Mammal prolactin variants
10/16/2003WO2003057152A3 Hair follicle growth
10/16/2003WO2003052061A3 Novel human proteins, polynucleotides encoding them and methods of using the same
10/16/2003WO2003051393A3 Enzymatic cleavable reagents for specific delivery to disease sites
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003046162A3 Process for the production of polypeptides in mammalian cell cultures
10/16/2003WO2003045320A3 Somatostatin analog and uses thereof
10/16/2003WO2003042661A8 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
10/16/2003WO2003042369A3 Cellular kinase targets and inhibitors, and methods for their use
10/16/2003WO2003042368A3 Methods of expressing lim mineralization protein in non-osseous cells
10/16/2003WO2003042356A3 Pttg knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
10/16/2003WO2003042238A3 Estrogen induced transcription modulating protein met
10/16/2003WO2003040311A3 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
10/16/2003WO2003040177A3 Nucleic acid derived from an alpv virus, compositions containing said nucleic acid and uses thereof
10/16/2003WO2003039555A3 Agents for treating lesions of the nervous system
10/16/2003WO2003038116A3 Salmonella virulence factors and uses thereof
10/16/2003WO2003037830A3 Photoactivatable composition and the use of same
10/16/2003WO2003033650A3 Recombinant renilla reniformis system for bioluminescence resonance energy transfer
10/16/2003WO2003031581A3 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith
10/16/2003WO2003031474A3 Cd137 as a proliferation factor for hematopoietic stem cells
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003027639A3 Glucocorticoid receptor nuclear translocation domain
10/16/2003WO2003027295A3 Methods for diagnosis and treatment of diseases associated with altered expression of jak1
10/16/2003WO2003027231A3 Polynucleotide encoding adapter protein, pmn29
10/16/2003WO2003022875A3 Polymorphisms of pd-1
10/16/2003WO2003020108A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/16/2003WO2003017937A3 Physalia fluorescent proteins
10/16/2003WO2003016496A3 Zinc finger binding domains for cnn
10/16/2003WO2003016487A3 Mammalian relaxin receptors
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003014160A3 Cd44 variants carrying heparan sulfate chains and uses thereof
10/16/2003WO2003014154A3 Vaccines against kaposi's sarcoma-associated herpesvirus
10/16/2003WO2003014077A3 Crystal forms and mutants of rank ligand
10/16/2003WO2003012394A3 Androgen receptor knock-out transgenic animals
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2003012047A3 Isolation of membrane bound ligand-specific complexes
10/16/2003WO2003011907A3 Receptor, the use thereof, and mouse antibodies
10/16/2003WO2003010288A3 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
10/16/2003WO2003010192A3 An inducer of apoptosis
10/16/2003WO2003008586A3 Engineering oncolytic viruses
10/16/2003WO2003005036A3 Epf receptor assays, compounds and therapeutic compositions
10/16/2003WO2003004704A3 Method of selecting dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2003002605A3 Human secretin-like g protein-coupled receptor
10/16/2003WO2003001902A3 Alteration of oil traits in plants
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2002102841A3 Identification and cloning of the receptor gene for symbiotic nitrogen fixation
10/16/2003WO2002102840A3 Multiners of class i major histocompatibility complexes cantaining modified beta2-microglobulin proteins
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002092839A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/16/2003WO2002088081A3 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
10/16/2003WO2002079428A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068680A3 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
10/16/2003WO2002068604A3 Polynucleotide encoding two novel human potassium channel beta-subunits, k+betam4 and k+betam5
10/16/2003WO2002063017A3 Integrin-binding chimeras
10/16/2003WO2002061089A3 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
10/16/2003WO2002060941A9 Fluorescent proteins
10/16/2003WO2002060930A3 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith
10/16/2003WO2002059606A3 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection
10/16/2003WO2002057495A3 A modeling framework for predicting the number, type, and distribution of crossovers in directed evolution experiments
10/16/2003WO2002055101A9 Storage stable powder compositions of interleukin-4 receptor
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002038588A3 Putrescine-n-methyltransferase promoter
10/16/2003WO2002032954A3 Phosphorylation modifications of apoptin
10/16/2003WO2002029074A3 Genetic immunisation against cervical carcinoma
10/16/2003WO2002018631A3 Diagnosis of illnesses or predisposition to certain illnesses
10/16/2003WO2002008442A3 Means and methods for raising antibody concentration in compartments of the body of a non human animal
10/16/2003WO2002004480A3 Connective tissue growth factor-2
10/16/2003WO2002002637A3 G-protein coupled receptors and nucleic acids encoding same
10/16/2003WO2001077356A3 Protein kinase stress-related proteins and methods of use in plants
1 ... 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 ... 2916